LAS VEGAS– Don’t underestimate the value of topical therapy for treating psoriasis patients, Dr. Linda Stein Gold said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.
Dr. Stein Gold explained how to overcome some of the compliance issues associated with topical therapies for psoriasis, and offered her suggestions for managing side effects in an interview at the meeting.
Dr. Stein Gold disclosed relationships with multiple pharmaceutical companies including Galderma, Stiefel, Allergan, Valeant, Ranbaxy, Promius, and Actavis.
SDEF and this news organization are owned by Frontline Medical Communications.